|
|
 | | | |
- close
- close
- close
- close
Bioinvent (STO:BINV) |
FierceBiotech
Oct 2
Comment
After a round a layoffs this summer, Lund, Sweden-based biotech BioInvent International has revealed further staff cutbacks as it hones in on cancer drug R&D. The biotech plans to let go of 20 jobs, adding to the 21 workers' positions axed this...
FierceBiotech
Jul 11
Comment
The news at Sweden's BioInvent is all bad. Last month its shares went into a meltdown after its lead drug–partnered with ThromboGenics--failed a head-to-head study with Xarelto. Roche ($RHHBY) then pulled out of a separate partnership and the...
FierceBiotech
Jun 29
Comment
Shares at Sweden's BioInvent went into meltdown mode earlier this month when an experimental blood-thinner it was developing in partnership with Thrombogenics ($THR) failed in a head-to-head study with Xarelto. Today the other foot dropped....
FierceBiotech
Jun 5
Comment
Shares went into meltdown mode at a pair of European biotechs today on news that their head-to-head study of an experimental bloodthinner backfired. An increase in bad bleeding incidents among patients on the companies' candidate, TB-402, compared...
FierceBiotech
Mar 12
Comment
Human Genome Sciences and BioInvent International have inked a deal to discover, develop and commercialize therapeutic monoclonal antibodies that specifically target antigens discovered by HGS. BioInvent will use its antibody discovery...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
